Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Peringkat dalam Saham #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Harga Saham
$0.5099
Terakhir disinkronkan: 2024-10-15
Kapitalisasi Pasar
$7.60M
Perubahan (1 hari)
2.02%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Anew Medical, Inc. (WENA)

Kategori

Laba untuk Anew Medical, Inc. (WENA)
Laba pada Jun 2024 TTM: $114.12K
Menurut laporan keuangan terbaru dari Anew Medical, Inc., laba saat ini perusahaan adalah $114.12K. Pada tahun 2022, perusahaan memperoleh laba sebesar $1.56M, peningkatan dibandingkan laba tahun 2021 sebesar $-1.11M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Anew Medical, Inc. dari 2021 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$5.27B 4,622,261.26%
US
$1.95B 1,709,242.25%
NL
- -
CH
- -
KR
$3.01B 2,633,790.84%
BE